Archive

Antimicrobial susceptibility of priority bacterial pathogens from laboratory samples in Timor-Leste: a retrospective analysis of database (2020-2025).

Ceftriaxone susceptibility was 65% (410/631) in E. coli and 25% (135/541) in K. pneumoniae. Meropenem susceptibility in E. coli fell from 100% (33/33) in 2020 to 87% (155/178) in 2024 (p=0.0002).

General Medicine · Lancet regional health. Southeast Asia · 20 Aug

FDA Approves First Therapy for Patients aged 8 years and older with Glycogen Storage Disease Type Ia

First gene therapy for GSDIa; consider referring eligible patients aged 8+ for this one-time option to reduce metabolic crises.

General Medicine · FDA — Press Announcements · 20 Aug

FDA Authorizes First-Of-Its-Kind Robotic Blood Draw Device

Automates phlebotomy, reducing needle-stick errors and freeing staff—consider workflow impact if adopted in Indian hospitals.

General Medicine · FDA — Press Announcements · 19 Aug

FDA Seeks Public Feedback to Inform Regulatory Approach for Generative AI-Enabled Medical Devices

Shaping FDA rules for generative AI devices will influence global standards, affecting your future adoption of AI tools in practice.

Medicine · FDA — Press Announcements · 18 Aug

Trends of congenital rubella syndrome among infants (0-11 months old) in India: a multicentre hospital-based sentinel surveillance (2016-2025).

Laboratory-confirmed CRS in 583 of 8953 (6.5%). Proportion declined from 24.9% in 2017 to 2.5% in 2025. One-year mortality 32.2% (95% CI 26.7-38.4).

Medicine · Lancet regional health. Southeast Asia · 11 Aug

FDA Approves New Engineered Viral Immunotherapy for Patients with Treatment-Resistant Advanced Melanoma

For patients with advanced melanoma who've exhausted checkpoint inhibitors, this new oncolytic virus offers a novel mechanism and a new option.

Oncology · FDA — Press Announcements · 7 Aug

Factors influencing antimicrobial stewardship implementation in healthcare facilities in four countries of Southeast Asia: a mixed-methods study (2022-23).

All four countries had national AMS policies; two had financing mechanisms. Mean facility G-ASET score was 241/335 (72%); training and education lowest at 17/25 (66%), tracking, monitoring, and reporting highest at 56/75 (75%).

Medicine · Lancet regional health. Southeast Asia · 6 Aug

FDA Approves First Drug to Treat the Full Range of Narcolepsy Type 1 Symptoms

For adults with narcolepsy type 1, this first full-spectrum oral option may reduce cataplexy and sleepiness, offering an alternative to stimulants and sodium oxybate.

Neurology · FDA — Press Announcements · 6 Aug

Two-day versus three-day systemic antibiotic prophylaxis for Gustilo-Anderson type IIIA and IIIB open tibial fractures (PROACT): a randomised controlled trial.

90-day surgical-site infection occurred in 15/104 (14%) with 2-day vs 18/100 (18%) with 3-day; risk difference -3.6% (95% CI -14.0 to 7.0, p=0.60). No significant difference.

Orthopaedics · Lancet regional health. Southeast Asia · 1 Aug

Mortality and cost of therapy of carbapenem susceptible vs resistant Gram-negative infections among hospitalised patients in India: a multicentric surveillance (2022-2025).

Carbapenem resistance increased mortality risk: E. coli RR 1.41 (95% CI 1.13-1.70), K. pneumoniae RR 1.33 (1.18-1.51), A. baumannii RR 1.16 (1.02-1.34), P. aeruginosa RR 1.43 (1.15-1.92). Bloodstream CR non-fermenter mortality 46.4-50.8%.

Medicine · Lancet regional health. Southeast Asia · 30 Jul

FDA Licenses First-Ever Freeze-Dried Plasma Product in the U.S.

Gives you a shelf-stable plasma option when conventional products are unavailable—useful in remote or austere settings for adult transfusion.

General Medicine · FDA — Press Announcements · 29 Jul

Antimicrobial stewardship programme in Sri Lanka: insights from early implementation experience (2024-2025).

Implementation exceeded 50% across all key performance indicators. AWaRe classification integration had the highest uptake at 74%; functional AMS teams and point prevalence surveys reached 52%.

General Medicine · Lancet regional health. Southeast Asia · 27 Jul

FDA Approves First Oral PCSK9 Inhibitor to Lower LDL Cholesterol in Adults with High Cholesterol

Offers an oral alternative to injectable PCSK9 inhibitors, potentially improving adherence for your high-cholesterol patients who avoid injections.

Cardiology · FDA — Press Announcements · 17 Jul

How Shared Clinical Decision-Making Can Shape the Metastatic Prostate Cancer Journey

Engaging patients early in mCSPC decisions improves adherence and satisfaction; use shared decision-making to align treatment with patient values.

Oncology · Fierce Healthcare · 9 Jul

FDA Approves First Gene Therapy for Young Children with Sickle Cell Disease

Now offers a one-time cure option for children as young as 2 with recurrent crises, potentially ending years of transfusions and pain.

Paediatrics · FDA — Press Announcements · 2 Jul

FDA Approves New Treatment That Uses Donor Immune Cells to Prevent Serious Complications in Blood Cancer Patients

For patients undergoing allo-HSCT, TREGZI may reduce chronic GVHD risk, improving survival without adding major toxicity—consider for eligible adults.

Oncology · FDA — Press Announcements · 1 Jul

Auto-Seg (SO-0012), Spine Auto-Seg (SO-0012) — Agada Medical, Ltd. (FDA K253628)

Automated spine segmentation on imaging can cut contouring time and variability, letting you focus on interpretation and reporting.

Radiology · FDA — AI/ML-Enabled Medical Devices · 29 Jun

ADAS 3D — Adas3D Medical S.L. (FDA K253969)

If you read breast MRI, this AI tool may automate 3D lesion analysis, potentially cutting reading time and improving consistency in reporting.

Radiology · FDA — AI/ML-Enabled Medical Devices · 29 Jun

Alturion Series Diagnostic Ultrasound System — Philips Ultrasound, LLC (FDA K260667)

A new Philips ultrasound platform cleared for radiology use — check its transducer and workflow features before adopting in your department.

Radiology · FDA — AI/ML-Enabled Medical Devices · 29 Jun

SOMNUM (SOMNUM) — Honeynaps Co., Ltd. (FDA K253390)

This AI-enabled neurology device gains US clearance; Indian clinicians should watch for local availability to aid neurological assessments.

Neurology · FDA — AI/ML-Enabled Medical Devices · 27 Jun

MammoScreen® (5) — Therapixel (FDA K260714)

Adds an FDA-cleared AI reader for mammograms; may help flag suspicious lesions and reduce missed cancers in your screening workflow.

Radiology · FDA — AI/ML-Enabled Medical Devices · 26 Jun

syngo.CT Coronary Cockpit — Siemens Medical Solutions USA, Inc. (FDA K253786)

This AI tool automates coronary CT analysis, potentially reducing reading time and variability in your radiology workflow.

Radiology · FDA — AI/ML-Enabled Medical Devices · 25 Jun

Enhanced Boundary for PCCT — Ge Medical Systems, LLC (FDA K253560)

This AI tool sharpens boundaries on photon-counting CT, potentially improving lesion delineation and reducing repeat scans in daily radiology practice.

Radiology · FDA — AI/ML-Enabled Medical Devices · 24 Jun

CMN Capillary Function with Oncology Virtual Expert — Cercare Medical A/S (FDA K260316)

This FDA-cleared AI tool quantifies capillary function in oncology imaging, potentially aiding tumor perfusion assessment and treatment response monitoring in your radiology practice.

Radiology · FDA — AI/ML-Enabled Medical Devices · 22 Jun

RX-1 Sleep — Vivaquant, Inc. Dba Rhythm Express (FDA K253148)

If you monitor sleep or sedation in perioperative care, this cleared device may offer a new non-invasive option for tracking sleep stages.

Anaesthesiology · FDA — AI/ML-Enabled Medical Devices · 22 Jun

ARTHUR — ROPCA ApS (FDA K260190)

This FDA clearance adds an AI radiology tool to your workflow; check if it fits your imaging needs before adopting.

Radiology · FDA — AI/ML-Enabled Medical Devices · 18 Jun

RadOncAI — Informai (FDA K253050)

AI-assisted radiotherapy planning may reduce contouring time and variability; check if it fits your workflow before adopting.

Radiology · FDA — AI/ML-Enabled Medical Devices · 18 Jun

Vascular Assist Occlusion Triage (VAOT) (v1.0) — GuideAI Health (FDA K260729)

This AI triage tool flags vascular occlusions on CTAs, helping you prioritize urgent reads and reduce time-to-treatment.

Radiology · FDA — AI/ML-Enabled Medical Devices · 18 Jun

ACUSON Sequoia Diagnostic Ultrasound System;ACUSON Sequoia Select Diagnostic Ultrasound System;ACUSON Origin Diagnostic Ultrasound System;ACUSON Origin ICE Diagnostic Ultrasound System — Siemens Medical Solutions USA, Inc. (FDA K260844)

Siemens ultrasound systems now cleared with AI/ML features; if you use these machines, check which algorithms are enabled for your workflow.

Radiology · FDA — AI/ML-Enabled Medical Devices · 16 Jun

LungMaps — Siemens Healthineers AG (FDA K253690)

Gives radiologists an FDA-cleared AI tool for lung mapping, potentially streamlining nodule tracking and surgical planning in daily chest CT reads.

Radiology · FDA — AI/ML-Enabled Medical Devices · 15 Jun

WatchMate Software — Anumana, Inc. (FDA K260300)

AI ECG analysis may flag cardiac risk earlier in routine radiology workflows, prompting timely cardiology referral.

Cardiology · FDA — AI/ML-Enabled Medical Devices · 15 Jun

Saige-Dx — DeepHealth, Inc. (FDA K253825)

Saige-Dx is an AI mammography tool now FDA-cleared; consider its role in your workflow to flag suspicious findings and reduce missed cancers.

Radiology · FDA — AI/ML-Enabled Medical Devices · 15 Jun

MediAI-OA — Crescom Co., Ltd. (FDA K253172)

If you read knee X-rays, this AI may flag osteoarthritis earlier, prompting timely referrals and management.

Radiology · FDA — AI/ML-Enabled Medical Devices · 15 Jun

Brainomix 360 Hyperdensity — Brainomix Limited (FDA K260406)

Automates hyperdensity detection on CT to speed stroke triage and thrombectomy decisions; useful for radiologists and emergency teams.

Radiology · FDA — AI/ML-Enabled Medical Devices · 12 Jun

Acorn 3D Software (AC-SEG-4009); Acorn 3DP Model (AC-101-XX) — Mighty Oak Medical (FDA K260322)

This clearance may enable more precise 3D-printed models for surgical planning, potentially improving outcomes in complex spine cases.

Radiology · FDA — AI/ML-Enabled Medical Devices · 11 Jun

DeepXray Spina — Alpha Intelligence Manifolds, Inc. (FDA K253192)

AI tool cleared for spinal imaging; consider workflow integration for faster, consistent reads in your radiology practice.

Radiology · FDA — AI/ML-Enabled Medical Devices · 10 Jun

EchoNext — Pathwai, Inc. (FDA K260332)

AI-assisted echo analysis may speed up your workflow and flag subtle findings, but clinical validation is limited—use as an adjunct, not a replacement.

Cardiology · FDA — AI/ML-Enabled Medical Devices · 8 Jun